pelvic endmetriosis
Conditions
Interventions
Group A:GnRH-a, 3.75mg, hypodermic injection or intramuscular injection, once a month. Or gestrinone 2.5 mg, twice a week
Group B:oral medication of Chinese herbal medicine, qd
Sponsors
Department of Science and Technology, State Administration of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: (1) meet the diagnose standards and TCM standars of pelvic endometriosis; (2) no history of serious drug allergy; (3) no history of surgery or laparoscopic operation due to pelvic endometriosis; (4) no medication for this desease in the previous 6 months before the operation; (5) no history of serious primary diseases such as cardiovascular and cerebrovascular diseases, liver diseases, kidney diseases or hematopoietic system diseases, no history of mental diseases; (6) women without lactation; (7) aged from 18 to 45; (8) the clinical classification belongs to ovarian endometriosis (endometrial cyst) and/or deep infiltrating endometriosis (the depth of lesions infiltration >=5mm, usually seen in the areas of utero-sacral ligament, douglas pouch, vaginal fornix and vagina-rectum); (9) patients recieved the first conservative surgery for pelvic endometriosis would be grouped during the 1-5th day of first menstruation; (10) patients sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) complicated with adenomyosis; (2) medication due to this disease after the operation or before the group allocation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CA125;B-ultrasonic scan;Chronic Pelvic Pain Scor; | — |
Secondary
| Measure | Time frame |
|---|---|
| Menstruation Score;Gestational conditions;Whole Body Symptoms Score;Dysmenorrhea Score; | — |
Contacts
Public ContactRuihua Zhao
Outcome results
None listed